Richard Burr, former US senator and current chair of DLA Piper’s Health Policy Strategic Consulting practice, talks with Julie Gerberding, former director of the U.S. Centers for Disease Control and Prevention (CDC) and current CEO of the Foundation for the National Institutes of Health (FNIH). The wide-ranging conversation includes thoughts on the Pandemic and All-Hazards Preparedness Act (PAHPA), lessons learned from COVID-19, and potential benefits of AI in therapeutic research and development.

New Perimeter at 20: Two decades of impact through global pro bono
34:35

Reform on the horizon: International tax in a 2025 reconciliation scenario
20:49

Investment frontier: The growing ties between the Middle East and Miami
27:33